It is prudent to monitor cardiac function in a patient in treatment with TKIs over the long-term,
and it is imperative to act immediately if the patient develops signs or symptoms of heart failure.
Reversible Cardiotoxicity with tyrosine kinase inhibitors
http://<span class="...010-francis.pdf
Other link: http://www.cmleukemi...span>heart.html
